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Bystander Attenuation of Neuronal and Astrocyte Intercellular Communication by 
Murine Cytomegalovirus Infection of Glia 
 
Abstract 
Astrocytes are the first cells infected by murine cytomegalovirus (MCMV) in primary 
cultures of brain. These cells play key roles in intercellular signaling and neuronal 
development, and they modulate synaptic activity within the nervous system. Using 
ratiometric fura-2 digital calcium imaging of >8,000 neurons and glia, we found that 
MCMV-infected astrocytes showed an increase in intracellular basal calcium levels 
and an enhanced response to neuroactive substances, including glutamate and 
ATP, and to high potassium levels. Cultured neurons with no sign of MCMV infection 
showed attenuated synaptic signaling after infection of the underlying astrocyte 
substrate, and intercellular communication between astrocytes with no sign of 
infection was reduced by the presence of infected glia. These bystander effects 
would tend to cause further deterioration of cellular communication in the brain in 
addition to the problems caused by the loss of directly infected cells. 
 
The results of this thesis project is published in the following peer-reviewed article: 
 
Ho WS, van den Pol AN. Bystander attenuation of neuronal and astrocyte 
intercellular communication by murine cytomegalovirus infection of glia. J Virol. 2007 
Jul;81(13):7286-92.
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Introduction 
Cytomegalovirus (CMV) is a source of significant public health concern. It is a 
common opportunistic agent of infection in immunocompromised individuals. In 
immunocompetent pregnant women, CMV infection can lead to congenital infection 
of the fetus with potentially devastating outcome. Congenital CMV infection can 
result in serious neurodevelopmental problems ranging from malformation of cortical 
development, mental retardation, cerebral palsy, to sensorineural hearing loss [1]. 
These injuries once incurred on the developing nervous system are often 
irreversible. The mechanism of injury with which CMV causes these significant but 
variable neurologic sequelae is largely unknown. Understanding the pathogenesis is 
pivotal in formulating improved modality of treatment and prevention. This project 
aims to study the impact of CMV infection on the calcium physiology of neurons and 
astrocytes using in-vitro Fura- 2 calcium imaging of intracellular calcium levels. The 
murine model was used in this project given the high degree of similarity between 
the genome of murine CMV and human CMV. The infectious characteristics 
between human and mouse CMV infection were also comparable [1].  
 
Background 
Cytomegalovirus –  
CMV is a member of the beta herpesvirus subfamily. It has a double stranded and 
linear DNA genome of 229 kbp that is largest in the herpes family. CMV is a family of 
viruses that include species-specific strains that do not cross host species carrier: 
human (HCMV), mouse (MCMV), chimpanzee (CCMV) and rhesus (RhCMV) [2]. 
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Similar to all herpes virus, CMV infection leads to lifelong latency in the host with 
intermittent reactivations. In humans, congenital CMV infection occurs through 
mother-to-child transmission, via either intra-uterine placental transmission or 
perinatal transmission during delivery or breast-feeding. In contrast to intra-uterine 
transmission, perinatal infections of full-term babies do not normally result in long-
term neurodevelopmental disabilities. Transplacental transmission occurs when 
pregnant women gain exposure to the virus during gestation. Primary infection 
occurs when the mother is seronegative for CMV, meaning that the mother has no 
previous exposure to the virus prior to pregnancy. In non-primary infection, the 
pregnant woman is seropositive, meaning that the mother is latently infected with 
CMV and is re-exposed to the virus during pregnancy [1]. The rate of transplacental 
transmission is higher in primary infection, estimated at between 24-75% [3-6], while 
the rate of transmission in non-primary infection is 2.2% [3, 5, 6]. However, there is 
evidence to suggest that the clinical outcome of is more severe in non-primary 
infection, possibly related to reinfection with a new strain of the CMV virus[3, 7, 8]. 
CMV is a ubiquitous virus. Age-adjusted prevalence of CMV is about 60%. In 
children, 0.5-1% acquire in-utero infection, 40% acquire latent infection by the age of 
10. By the age of 60, an estimated >80% of the population is infected with the 
virus[1, 6, 9]. In non-congenital infection of immunocompetent individuals, the virus 
causes minimal clinical consequence.  
 
Epidemiology of congenital CMV infection –  
In the United States, congenital CMV infection accounts for a major cause of birth 
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defects and childhood disorder. An estimated 0.2-2% of all deliveries, or about 
40,000 children, were infected by CMV yearly. An estimated 400 fatalities directly 
result from congenital CMV infection. At birth, only about 15% of CMV infected 
babies are symptomatic. Clinical manifestations include intrauterine growth 
restriction, hepatosplenomegaly, jaundice, thrombocytopenia, microcephaly, 
periventricular calcifications, and chorioretinitis [2].  About 60-90% of symptomatic 
infant will have long-term neurologic deficits.  An additional 10-15% of asymptomatic 
children at birth ultimately will develop neurodevelopmental disabilities, which can 
have variable clinical presentations ranging from mental retardation, psychomotor 
retardation, hearing loss and ophthalmologic abnormalities[1]. An estimated 
incidence of 8000 children/year with neurodevelopmental deficits is attributed to 
congenital CMV infection. To put this in perspective with other prominent causes of 
congenital birth defects, Down syndrome affects 4000 children/year [1, 7], fetal 
alcohol syndrome affects 5000 children/year, and spinal bifida affects 3500 
children/year [1, 10]. Hence, congenital CMV infection is the most common cause of 
birth defects and childhood disabilities in the United States.  
 
Diagnosis of in-utero CMV infection –  
Given the potentially long-term consequence of congenital CMV infection, accurate 
diagnosis of CMV infection in pregnancy, especially primary infection, which carries 
a higher rate of in-utero transmission, is desired. In most cases, CMV infections of 
pregnant women are asymptotic. Even in the acute phase, less than 5% of mothers 
demonstrate any symptoms and even fewer have full-blown mononucleosis 
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syndrome [3]. To diagnosis primary infection, one needs to demonstrate 
seroconversion, meaning a positive anti-CMV IgM antibody with documented 
negative test prior to gestation. Since anti-CMV IgM antibodies are not routinely 
tested, rarely can seroconversion be documented. The presence of anti-CMV IgM 
alone does not correlate with primary infection, since IgM can be produced in 
reactivation of latent infection or infection of carrier with new strain. Currently, the 
most reliable test for primary CMV infection is anti-CMV IgG avidity test. Carrier with 
latent infection will have high avidity anti-CMV IgG while primary infection will have 
low anti-CMV IgG. The sensitivity and specificity of the avidity test conducted before 
18-week gestation are reported as high as 92-100% and 82-100% respectively [3, 
11-15]. For the diagnosis of CMV infection in the newborn, the gold standard is 
isolation of virus in the urine and/or saliva within first two or three weeks of life. 
Serologic test for anti-IgM only carry a sensitivity of 70%. Beyond, 2-3 weeks of life, 
serologic or virologic test do not differentiate between congenital and perinatal 
infection [3].  
 
CMV Pathology –  
The most devastating long-term clinical manifestation of congenital CMV is the 
irreversible damage on the developing nervous system. The earliest structural 
abnormalities can be detected by fetal imaging studies at 28 weeks of gestation. 
Magnetic Resonance Imaging (MRI) or ultrasonogram can demonstrate white matter 
abnormalities resulting from acute responses of focal necrosis and hemorrhaging. 
Transvaginal ultrasonograms can demonstrate a range of structural anomalies, 
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including ventricular adhesions, periventrcular cysts, ependymal protrusions and 
abnormal sulcations. The pattern of structural abnormalities on fetal imaging studies 
is useful in determining time and extent of fetal infection, which can have prognostic 
value [1]. In neonatal and postnatal imagining, children who are symptomatic at birth 
always are associated with structural brain abnormalities. The most common is 
intracranial calcification (Fig. 1A). Other changes include ventriculomegaly, 
polymicrogyria cyst and encephalopathy. In more severe cases, severe 
malformation of cortical development such as polymicrogyria (Fig. 1B), 
lissencephaly, porencephaly, and schizencehaly (Fig. 1C) can be seen.  
 
In addition, congenital CMV infection is also the most common cause of 
nonhereditary sensorineural hearing loss (SNHL), accounting 10-60% of SNHL in 
children representing 0.2-1.3/1000 live births [1, 16]. SNHL from CMV infection can 
be clinically apparent at birth or can develop progressively over first several years of 
life. SNHL has much higher incidence in children who are symptomatic at birth (30-
65%) compared to those who are asymptomatic at birth (7-15%). SNHL is frequently 
the only long-term neurologic sequalae in CMV-infected children who are 
asymptomatic at birth [1, 17-19].  
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Fig. 1. Examples of neurodevelopmental abnormalities resulting from congenital CMV infection. (A) 
Computed tomography showing periventricular calcification. Magentic resonance image showing 
polymicrogyria (B), a neuronal migration abnormality, and schizencephaly with porencephalic cyst. 
Adopted from Cheeran et al.  
 
Calcium Imaging –  
Intracellular calcium plays a central role in a wide range of cellular physiological 
processes, from neuronal signaling, muscular contraction, paracrine exocytosis to 
apoptosis. Abnormalities in calcium signaling pathways have been implicated in a 
number of pathologies that affects systems as wide ranging as the nervous, 
cardiovascular, musculoskeletal to integumentary system [20]. Hence, the study of 
intracellular Ca2+ can be crucial in understanding the pathophysiological mechanism 
in a variety of disease processes. The use of fluorescent Ca2+ indicators to study 
intracellular Ca2+ has been a successful strategy. While there are a variety of Ca2+ 
indicators, they all share the attribute that their florescent properties shift with Ca2+ 
binding. Broadly, there are two major categories of Ca2+ indicators: genetically 
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encoded fluorescent proteins and chemical fluorophores. Genetically encoded 
florescent proteins require transfection or expression of the Ca2+ sensitive proteins 
in the cells prior to the experiments, while chemical indicators can be introduced and 
utilized rapidly [20]. The current project is performed exclusively using the chemical 




Fig. 2. Intensity of fluorescence plotted against 
excitation wavelength under different calcium 
concentrations. At 340 excitation, intensity 
increase with calcium concentration. At 380 





Fura-2 belong to a special class of chemical Ca2+ indicators known as ratiometric 
indicators. It has the special property that with Ca2+ binding the excitation spectrum 
changes. Specifically, the peak excitation absorbance shift from 380 in a Ca2+ free 
state to 340 nm in a Ca2+ bound state (Fig. 2). This allows for an accurate 
quantification of Ca2+ level based on the ratio of the fluorescent emission intensity 
at 340 and 380 excitation. This ratiometric quantity corrects for uneven dye loading, 
photobleaching, and changes in cellular volume. Hence, the use of Fura-2 allows the 
comparison of absolute Ca2+ level between different cells. This is property that is 
crucial in the experiments performed in the current project.     
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Astroctyes and neuronal Ca2+ physiology  –  
It has been shown previously that MCMV preferentially targets astrocytes in early 
stages of infection [21]. In the past years, the traditional view that astrocytes in the 
brain merely provide structural support for neurons has given way to the realization 
that astrocytes play critical and active roles in processing information, 
communicating with other glia, and modulating synaptic communication [22-24]. 
Astrocytes respond to and release transmitters such as glutamate and extracellular 
ATP through increases in intracellular Ca2+ [25-28]. Astrocytes modulate synaptic 
activity and respond to the release of transmitters from neurons [25, 27, 29, 30]. 
Astrocytes communicate with one another; intercellular Ca2+ elevations initiated in a 
single astrocyte can propagate to neighboring cells in a wavelike manner mediated 
by ATP release and enhanced by gap junctions [31-36]. Long-distance intercellular 
calcium waves occur spontaneously or are triggered by neurotransmitters such as 
ATP [28, 31] and glutamate [33, 37, 38]. In addition, astrocytes actively modulate 
synaptic transmission between neurons [30, 37, 39-42]. As astrocyte signaling plays 
a role in microglia activation and neurogenesis, the preferential MCMV affinity for 
astrocytes may play a crucial role in the pathogenesis of MCMV, and, therefore, 
understanding the impact of MCMV on astrocyte signaling may contribute to a 
greater understanding of the disease process. Although we are unaware of studies 
investigating ion shifts due to MCMV infection of brain cells, CMV infections of 
fibroblasts may increase cytoplasmic calcium, thereby possibly enhancing CMV 
replication [43]. In the present study, we examined the changes in astrocyte Ca2+ 
responses to glutamate, ATP, and depolarization by high K+ in the course of MCMV 
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infection. We also tested the hypothesis that infection of the underlying astrocyte 
substrate alters synaptic communication among co-cultured neurons. Finally, we 
examined whether intercellular Ca2+ waves between communicating glia are 
impeded by MCMV infection. 
 
Specific Aim: 
To study how calcium physiology is altered in mice astrocytes and neurons with 
MCMV infection using Fura-2 calcium imaging. Specifically, the Ca2+ responses in 
astrocytes to stimulation with glutamate, ATP and high K+ will be compared in 
different stages of MCMV infection. Neuronal synaptic activity will be compared 
between neurons with MCMV infected astrocytes substrate and control.  Finally, 
calcium waves stimulated by mechanical stimulation will be compared between 
MCMV infected and non-infected astrocytes.  
 
Materials and Methods: 
Tissue Culture (this part of the experiment is performed with the help of Dr. Yang, 
post-doc fellow in the lab) –  
Primary cultures were prepared from Swiss albino mouse brains harvested on 
postnatal day 5 and on embryonic day 17 for astrocyte and neuron preparations, 
respectively. Care was used to ensure that all cultures used in a particular 
comparison were of the same age and cell density. The brain tissue was harvested 
and placed in standard minimal essential culture media (GIBCO) and washed three 
times. The tissue was then enzymatically digested in Earl's balanced salt solution 
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containing papain (10 units/ml) and l-cysteine (0.2 mg/ml) for 30 min. The tissue was 
pelleted and the protease solution was removed by aspiration. The tissue was 
triturated into a single-cell suspension in tissue culture medium [glutamate- and 
glutamine-free Dulbecco's modified Eagle's medium (DMEM) supplemented with 
10% fetal bovine serum, 100 units/ml penicillin/streptomycin and 6 gm/l glucose]. 
The suspended cells were plated onto poly-d-lysine (540,000 Da) coated glass 
coverslips (22 mm2). For astrocyte-only cultures, the cells were maintained in vitro 
with minimal essential medium for up to 2 to 3 weeks before use. For high-density 
neuronal cultures, cells we plated within a 7-mm glass cylinder placed on top of the 
coverslip. The glass cylinder was removed 60 min after plating. Cytosine 
arabinofuranoside (2 µM) was then added to the tissue culture medium on the 
second day in culture to inhibit glial cell proliferation.  Cell cultures were maintained 
at 37°C and 5% CO2 in a Napco 5410 incubator. 
 
MCMV –  
Two different MCMV was used in the current project: a commercially purchased 
wild-type MCMV (Smith strain; ATCC), and a recombinant MCMV with enhanced 
Green Fluorescence Protein (GFP) expression, allowing identification of infected 
cells. GFP transcription was driven by an elongation factor 1a promoter, placed at 
the IE2 site, a site that did not alter viral replication or tissue preference. GFP 
expression could be found in infected brain cells within 6 h of CMV inoculation [44]. 
 
 









Fig. 3. Calcium imaging experimental setup. A computer controlled shutter wheel alters between 340 
and 380 excitation. Ratiometric image can be calculated using those two images and calibrated to an 
absolute Ca 2+ level.   
 
Calcium imaging –  
Fura-2 ratiometric calcium imaging was employed to monitor intracellular calcium 
levels. Cells were incubated with 5 µM fura-2 acetoxymethyl ester for 30 min at 37°C 
in standard HEPES buffer solution (10 HEPES, 137 mM NaCl, 25 mM glucose, 5 
mM KCl, 1 mM MgCl2, 3 mM CaCl2, pH 7.4). Cultures growing on glass coverslips 
were then loaded into a laminar-flow perfusion chamber for image acquisition. 
Ratiometric images were taken every 3 seconds by alternating between 340-nm and 
380-nm excitation wavelengths using a Sutter filter wheel controlled by a Sutter 
Lambda 10-2 microprocessor (Fig. 3). Ratiometric values were then calibrated to 
Ca2+ with a standard curve established using a fura-2 calcium calibration kit 
(Invitrogen). Images were acquired using a QImaging Retiga EX digital camera and 
processed with Openlab and IGOR Pro software running on an Apple G5 computer. 
In some cases, image contrast was corrected by using Adobe Photoshop; all images 
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in a set were treated simultaneously and in the same fashion to avoid data bias. 
Ca2+ level of individual cells was inferred by selecting regions of interests in the field 
of view and the Ca2+ level of each cell can be monitored over the course of the 
time-lapse recording simultaneously.  
 
Basal Ca2+ -  
To assess the change in basal calcium levels of astrocytes with MCMV infection, 
cultures enriched in astrocytes were infected with MCMV (2.5 × 104 PFU/ml). We 
recorded the basal Ca2+ level at 2 and 3 days postinfection (dpi) of over thousands 
of astrocytes. Comparison was made between the basal Ca2+ of infected astrocytes 
with non-infected controls. To assess if the degree of basal Ca2+ change is 
dependent on viral load, two different doses, Multiplicity of Infection (MOI) of 1 and 
5, were used to compare change in basal Ca2+ with noninfected controls. MOI was 
based on estimating culture cell density by counting number of cells in three high 
field view and extrapolating the total number of cells in the culture dish. MOI of 1 
represents a viral dosage with a one-to-one viron to cell ratio, while MOI of 5 
represents a five-to-one ratio. 
 
Astrocyte Ca2+ response to stimulation –  
The change in astrocyte Ca2+ response to stimulation with glutamate (100 µM), high 
K+ (55 mM), and ATP (10 µM), was assessed. Stimulation was performed by 
changing the perfusion buffer of the chamber with the desired stimulus. An infection 
dose of 0.5 MOI was used for these experiments. The Ca2+ responses to these 
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stimuli were assessed at two different time points of infection, 2DPI and 3 DPI, and 
were compared to non-infected controls. Ca2+ response was calculated by 
subtracting the basal Ca2+ (average of 20 seconds of Ca2+ level before stimulation 
started) from the stimulated Ca2+ (average of 20 seconds of Ca2+ after stimulation 
started). 
 
Bystander effect on neuronal synaptic activity –  
To test the hypothesis that MCMV infection of astrocytes may change neuronal 
communication, mixed astrocyte-neuron cultures were infected with low levels of 
MCMV-GFP (MOI 0.5). Experiments were performed at a time when there was clear 
infection of the underlying astrocytes but little or no infection of the overlaying 
neurons. The cells were electrically stimulated (ES) using electrodes on opposite 
edges of the recording chamber with a Grass SD9 stimulator. A rise in Ca2+ levels 
was triggered by passing a current of 0.06 V/mm2 through the chamber for 3 ms at 7 
Hz. To demonstrate that the observed rise in Ca2+ was a result of activated synaptic 
activity of neurons, ES under tetrodotoxin (TTX) at 10 uM or ionotropic glutamate 
receptor antagonists (AP5 [dl-2-amino-5-phosphonopentanoic acid] at 100 µM and 
CNQX [6-cyano-7-nitroquinoxaline-2,3-dione] at 10 µM) was used to chemically 
block the ability of neurons to conduct action potential. ES under such conditions 
was used to show if the ES-dependent Ca2+ rise was dependent on neuronal 
synaptic activity and not direct activation of voltage Ca2+ channels.  
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Calcium Waves –  
To examine how MCMV infection alters the propagation of glial waves. Astrocyte-
enriched cultures were infected with GFP-MCMV at MOI of 1. Experiments were 
conducted at 2 dpi when there some percentage of astrocytes had clear GFP 
expression. Calcium waves in astrocyte-enriched cultures were triggered by light 
mechanical stimulation with a glass pipette that led to an intercellular Ca2+ wave. 
The impact of infection was assessed by examining 3 distinct properties of the wave: 
total distance traveled, total number of cells involved and propagation velocity. Total 
distance of waves was measured by the greatest radial distance between the point 
of stimulation and the furthest point of Ca2+ increase. The total number of cells was 
tallied by counting the number of cells with Ca2+ after stimulation. Maximum wave 
velocity was assessed by the largest distance traveled between each frame of the 
acquisition during wave propagation. A large number of wave samples was collected 
to make a collective comparison between infected cultures and noninfected controls.  
 
Results 
Basal Ca+ changes - We monitored the basal Ca2+ level at 2 and 3 days 
postinfection (dpi) and found an increase from a Ca2+ level of 105 ± 1 nM (mean ± 
standard error) in noninfected controls to 146 ± 3 nM in MCMV-infected cells at 3 dpi 
(n = 4,050, P < 0.05, analysis of variance [ANOVA] with the Bonferroni procedure) 
(Fig. 3A). In a separate experiment, we examined the changes in the basal Ca2+ 
levels by using different concentrations of the virus. Basal Ca2+ levels at 1 dpi 
showed an increase from 125 ± 1.9 nM in control cells (n = 658) to 132 ± 2.1 nM at a 
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multiplicity of infection (MOI) of 1 (n = 605, P < 0.05) and to 221 ± 2.7 nM at an MOI 
of 5 (n = 811, P < 0.01). To avoid minor differences in Ca2+ responses from one 
region of the coverslip to another, each group is based on more than six imaging 








Fig. 3. (A) The mean basal intracellular Ca2+ level in astrocytes is increased by MCMV at 2 and 3 dpi. 









Fig. 4A-B. Typical raw 340-nm and 380-nm excitation images and ratiometric images of 340/380 
calibrated to Ca2+ in pseudocolor show a color spectrum from blue (representing low Ca2+) to red 
(representing high Ca2+) of uninfected and infected cells, respectively (scale bar, 50 µm). 
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Fig. 5A-B. Representative Ca2+ traces of astrocyte responses to glutamate (Glut), a high level of K+, 
and ATP in uninfected (A) and infected (B) cells. 
 
Astrocyte Ca2+ response to stimulation –  
Calcium responses to stimulation by glutamate (100 µM), high K+ (55 mM), and ATP 
(10 µM) were examined in astrocytes infected with wild-type MCMV at MOI 0.5. In 
Fig. 4 typical raw 340-nm and 380-nm excitation images and ratiometric images of 
340/380 calibrated to Ca2+ were shown for uninfected (Fig. 4A) and infected (Fig.4B) 
cells. Calcium levels of individual cells were graphed by selecting regions of interest 
corresponding to each cell in the calibrated images. Representative traces of Ca2+ 
changes in response to glutamate, high K+ and ATP are shown in Fig. 5. Responses 
in uninfected controls, infected cells at 2 dpi and 3dpi were examined. At 2 dpi, 
MCMV infected astrocytes showed a greater rise in intracellular calcium 
concentration than did noninfected control cells when stimulated with ATP (Fig. 6A), 
high K+ (Fig. 6B) and glutamate (Fig. 6C) suggesting that MCMV enhances the 
calcium response to a number of neuroactive substances (n = 1,088, P < 0.05, 
ANOVA with Bonferroni procedure); only responding cells were included in the data 
means. This finding is interesting as it suggests that the astrocytes become 
hypersensitive to neurotransmitter stimulation in the course of infection. This 
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sensitization appears to be general to all three agents tested, suggesting an altered 
sensitivity of the glutamate and extracellular purinergic ATP receptor responses as 
well as the voltage-gated calcium channels stimulated by high K+. At 3 dpi, cells no 
longer showed an exaggerated calcium response to ATP, glutamate, or high K+. 
Given the central roles that glutamate and ATP play in intercellular glia-glia and 
neuron-glia communications [41, 45-47], the altered astrocyte responses to these 
neurotransmitters may impede normal functioning of the nervous system. The 
percentage of cells responding to the different stimulations during the course of CMV 
infection was also examined. The response to ATP was robust, with almost all cells 
still responding at 3 dpi, whereas the percentage of cells showing a detectable rise 
in Ca2+ levels due to high K+ and glutamate fell to 66% and 20%, respectively, at 3 
dpi (Fig. 6D). This suggests that there is a sequence (glutamate → high K+ → ATP) 
in which astrocytes become unresponsive to the three stimulations as infection 
proceeds. Another notable observation is that in response to ATP, a markedly higher 
percentage of infected astrocytes show repetitive oscillations in Ca2+ levels from 3% 
± 0.8% in noninfected control cells to 29% ± 5.1% at 2 dpi (n = 1,006, P < 0.05, two-
tailed t test) (Fig. 6E). These oscillations occur in single cells and are characterized 
by a rise and fall in calcium levels over a period of about 15 s. This suggests that 
infected cells did not sustain a consistently elevated Ca2+ response but, rather, 
oscillations in the Ca2+ response in the form of multiple peaks. At 3 dpi, the 
oscillations were not sustained and the response to ATP came mostly in a single 
peak.  
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Fig. 6. Change in Ca2+ response to chemical stimulation in MCMV infected astrocytes. At 2 dpi, 
infected cells show increased responses to ATP (A), a high level of K+ (B), and glutamate (C). This 
exaggerated response was lost by 3 dpi. (D) The proportion of cells responding to glutamate (Glut) 
and a high level of K+ decreased at 2 and 3 dpi. However, almost all cells retained responsiveness to 
ATP stimulation. (K) The percentage of cells displaying a high level of oscillations in Ca2+ 
concentration during ATP stimulation increased after infection. (L) Using a GFP-expressing MCMV, 
the degree of Ca2+ concentration oscillations in response to ATP as determined by the standard 
deviation of Ca2+ concentration is correlated with GFP intensity, suggesting that increased levels of 
MCMV infection are correlated with a greater degree of Ca2+ oscillations. 
 
Using the recombinant GFP-MCMV strain, the detection of MCMV infection was 
correlated with the expression of the reporter gene. In a separate experiment in 
which astrocytes were infected with the MCMV-GFP strain, cells were divided into 
three groups based on the measured fluorescence intensity of the GFP signal, 
determined by using a 12-bit digital camera (low, 0 to 500; medium, 500 to 1,500; 
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and high, 1,500 to 4,095). The level of Ca2+ oscillations, based on the standard 
deviation in Ca2+ concentration under ATP perfusion, showed a statistically 
significant increase in the high-GFP group compared to the low- or medium-GFP 
groups (n = 474, P < 0.05, ANOVA with the Bonferroni procedure) (Fig. 6E), 
suggesting that cells with a higher level of infection showed more oscillations in 
calcium level. Glial Ca2+ oscillations may serve to orchestrate the release of, or 
response to, transmitters [30, 48]. 
 
In order to preclude the possibility that the observed changes in calcium levels were 
due to factors other than the process of MCMV infection, two control experiments 
were performed. Using MCMV-GFP, the basal Ca2+ levels of uninfected cells in 
infected mouse astrocyte cultures (2 dpi), selected by the absence of a GFP signal, 
were compared to those of noninfected control cultures. At 2 dpi, the mean basal 
Ca2+ level did not increase in the uninfected cells of infected cultures compared to 
that of the control cultures; mean Ca2+ concentrations were 169 ± 7 nM (n = 253) 
and 141 ± 19 nM (n = 151), respectively (P = 0.28). In a second control experiment, 
MCMV-GFP, inactivated with UV light for 5 h, was used to compare the Ca2+ 
responses of astrocytes to high K+ levels and ATP. At 2 dpi, responses in cultures 
inoculated with the inactivated virus showed no increase compared to the control: 
mean Ca2+ levels in response to high levels of K+ were 313 ± 12 nM (n = 127) in 
inoculated cells and 298 ± 13 nM in control cells (n = 113); the mean Ca2+ levels in 
response to ATP were 504 ± 22 nM (n = 134) in inoculated cells and 497 ± 20 nM in 
control cells (n = 113, P = 0.78). Inactivation was confirmed by the failure of MCMV-
	   23	  
GFP to express GFP in any cell, while the same amount of virus before UV 
treatment did express GFP at the same dpi. These experiments suggest that 
changes in Ca2+ levels are not attributable to contaminants in the inoculum but 
rather that active replicating virus is responsible. In addition, it is also shown that the 
MCMV-mediated increase in Ca2+ increase occurs selectively in infected astrocytes 
and not in bystander astrocytes in the same dish. 
 
 
Fig. 7. (A) In the presence of TTX, the neuron response to ES is completely abolished. This indicates 
that the Ca2+ increase in response to ES is attributed to an increase in synaptic activity and not to the 
direct activation of voltage-gated Ca2+ channels, supporting the use of the ES response as a measure 
of synaptic activation. The ES response recovered after the washout of TTX. (B) Two representative 
Ca2+ traces showing a complete block of the ES response in the presence of TTX as well as the 
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Bystander effect on neuronal synaptic activity –  
To address the question of whether neuronal synaptic activity is affected by MCMV 
infection of underlying astrocytes independent of infection of the neurons 
themselves, GFP-MCMV at MOI of 0.5 was used to infect mixed astrocyte-neuron 
cultures. As expected from known trophism of MCMV infection, astroctyes become 
preferentially infected at early stage of infection. As shown in Fig. 8B GFP 
expression comes exclusively from the astrocytes, not from neurons, in a field with 
high density for both cell types.  In the presence of tetrodotoxin (TTX) to block spike-
mediated transmitter releases, the electrically stimulated Ca2+ rise was completely 
eliminated (Fig. 7). Similarly, the ionotropic glutamate receptor antagonists (AP5 [dl-
2-amino-5-phosphonopentanoic acid] at 100 µM and CNQX [6-cyano-7-
nitroquinoxaline-2,3-dione] at 10 µM) blocked the stimulated response (not shown). 
Fig. 8 shows that the synaptic activity of neurons with infected underlying astrocytes 
becomes attenuated in comparison to that of the control cells. MCMV infection of 
astrocytes reduced the ES-mediated Ca2+ rise in neurons from 176 ± 6 nM in control 
cells to 131 ± 6 nM (n = 907, P < 0.05, two-tailed t test), suggesting that MCMV 
altered neuronal communication by the infection of astrocytes, even before the 
neurons showed any sign of infection. Since TTX blocks spike-mediated 
neurotransmitter release and glutamate receptor antagonists block the response to 
synaptic glutamate release, together these data support the view that the electrically 
evoked calcium rise is due to the synaptic release of glutamate and not to a direct 
effect of electrical stimulation on voltage-gated calcium channels. 
Fig.8D shows an additional control in which neuron-enriched cultures, in the 
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absence of an underlying astrocyte substrate, were inoculated with the MCMV at the 
same MOI as that described above. When used for calcium imaging, neurons did not 
show GFP expression or a cytopathic effect. This allows for the possibility that there 
may be a low level of infection of neurons that was not detected by measuring GFP 
expression and that could potentially alter neuronal signaling. Electrically evoked 
and synaptically mediated calcium level increases did not differ between control and 
MCMV-inoculated cultures; the change in Ca2+ level was +76 ± 4 nM in control 
cultures and +81 ± 4 nM in MCMV-inoculated cultures (n = 801, P > 0.3, two-tailed t 
test). This supports the view that an infected-astrocyte substrate is most likely 
responsible for the attenuation of neuronal synaptic communication. 
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Fig. 8. Astrocyte infection reduces neuron synaptic responses. (A and B) Ratiometric images of 
340/380 nm calibrated to Ca2+ show neuronal responses to ES and N-methyl-D-aspartic acid 
(NMDA). Synaptically linked neurons are identified by their responsiveness to both ES and NMDA, 
with confirmation based on morphology in brightfield images. The GFP intensity indicates the level of 
MCMV infection. Cells in red circles in panels B are neurons responding to ES and NMDA that are 
uninfected by MCMV as shown by the absence of GFP signal. Underlying astrocytes are, however, 
heavily infected, and show a bright GFP signal. Scale bar, 20 µm. (C) The change in the ES response 
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of neurons on infected astrocytes was lower than that on control neurons growing with uninfected 
astrocytes. The change in Ca2+ concentration decreased from 175 ± 6 nM in control cells to 132 ± 6 
nM in neurons with infected astrocytes. (D and E) Representative Ca2+ traces of neurons responding 
to ES and NMDA with normal astrocytes (D) and with MCMV-infected astrocytes (E). 
 
 
Fig. 8. (A) Ratiometric images of 340/380 nm calibrated to Ca2+ showing the neuronal responses to 
ES and NMDA (N-methyl-D-aspartic acid). The 340-nm and brightfield images show the absence of 
underlying astrocytes; the GFP image shows that the experiment is performed at a time when no 
MCMV reporter gene expression or cytopathic effect can be detected. Scale bar, 30 µm. (B) The 
mean ES response of neurons is unchanged in the absence of astrocyte infection. 
 
Calcium Wave –  
The effect of infection on the propagation of glial wave conducted by astrocytes was 
examined. Three properties of glial waves were studied: total distance travelled, total 
number of cells involved and maximum wave velocity. In Fig.9A-C, we demonstrated 
the glial waves triggered by mechanical stimulation in noninfected controls and 
MCMV infected astrocytes. MCMV infection strongly attenuated calcium wave 
propagation. In MCMV-infected astrocytes, the mean distance traveled in a single 
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triggered wave decreased from 434 ± 36 µm to 119 ± 23 µm, the mean number of 
cells in a wave decreased from 53 ± 5 cells to 19 ± 2 cells, and the maximum 
propagation velocity dropped from 15 ± 3 µm/s to 8 ± 1 µm/s (n = 54, P < 0.05, two-
tailed t test) (Fig. 9D-F). Given that glutamate and ATP are critical messengers in 
the propagation of calcium waves, it is possible that the change in the responses to 
ATP and glutamate described earlier contributes to the disruption of wave 
propagation. Fig. 9C also shows an interesting consequence of MCMV infection on 
the spatial distribution of waves in infected cells. Wave propagation is spatially 
limited by infected cells, demonstrating that those cells can form a barrier between 
astrocytes with no sign of infection, over which wave propagation is attenuated. To 
test further the effect of infection on intercellular glial signaling, astrocytes were 
grown in thin strips, and MCMV was focally applied by a micropipette to a single 
region of each strip. Three days later, noninfected astrocytes were stimulated, and 
the distance the wave traveled was measured. By focusing only on cells not 
expressing the MCMV-GFP reporter, calcium waves were found to be strongly 
attenuated in proximity to infected cells, reducing the distance the wave traveled 
from 554 ± 19 µm (n = 6) when the wave did not encounter infected cells to 264 ± 16 
µm (n = 6) when the wave met infected glia (not shown). Thus, MCMV reduces the 
velocity of and distance traveled by calcium waves in astrocytes. Importantly, the 
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FIG. 9. Intercellular Ca2+ waves are attenuated by MCMV. (A to C) Sequences of ratiometric images 
of 340/380 nm excitation in pseudocolor calibrated to Ca2+ show the progression of intercellular 
waves triggered by light mechanical stimulation in uninfected control astrocytes (A) and infected 
astrocytes (20 h postinfection) (B and C). Red arrows indicate points of stimulation. GFP images 
show the distribution of infected astrocytes. Intercellular Ca2+ waves are significantly inhibited in 
infected cells. Infected cells spatially confine the spread of a wave in other cells (C). Scale bar, 150 
µm. Note that the magnification is higher in panel C than in panels A and B. (D) The mean distance 
traveled by a wave is decreased in infected astrocytes. (E) The mean number of cells in a wave 




In summary, we have reported several observations of how astrocytes and neurons 
are affected my MCMV infection in an in-vitro model using Fura-2 Calcium imaging. 
First, we have shown that astrocytes are sensitized to a range of stimulation 
resulting in hyperexcitability during the course of CMV infection. Second, we have 
demonstrated that neuronal synaptic activity is attenuated when underlying 
astrocytes are infected. The attenuation of neuronal communication appears to be a 
bystander effect secondary to astrocyte infection, since no detectable infection was 
found in neurons. Third, we have also shown that CMV infection dramatically affects 
propagation of glia waves activities.  To extrapolate the relevance of these 
observations in-vivo in the setting of congenital CMV infection, one has to review the 
current understanding of the role astrocytes play in the nervous system. In the last 
decade, there is a paradigm shift in the concept of the functional importance of 
astrocytes in neuronal communications. In the past, it was assumed that astrocytes 
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merely form a passive framework that acts as a substrate for overlying neurons. But 
recent findings suggest that they do a lot more, and the idea of the “tripartite 
synapse” arose [49] (Fig. 10). A tripartite synapse comprise of the pre- and post- 
synaptic neurons as well as the glial processes that ensheath the junction [40]. The 
astrocytes regulate the microenvironment around synapse. It recycles the released 
glutamate in the form of glutamine to the presynaptic neurons and maintains ion 
homeostatsis of extracellular K+ concentration and pH [49]. In addition, a new 
subtype of glial cells, known as the oligodendrocyte precursors cells (OPCs) was 
recently identified. OPCs express proteoglycan NG2 and distinct physiologic and 
morphologic characteristic from other glial types [49-51]. OPC have been shown to 
conduct fast synaptic transmission mediated by GABA or glutamate [49, 52-55], 
highlighting the possibility of an even more integral role astrocytes play in the 









   
 








Fig. 10. Schematic representation of a tripartite synapse. Perisynaptic astrocyte (blue cells) 
processes contain transporters that take up glutamate (Glu, green circles) that has been released into 
the synapse and return it to neurons in the form of glutamine (Gln). Glutamate receptors on 
astrocytes sense synaptic glutamate release, which in turn induces a rise in Ca2+ concentration in the 
astrocytes. One of the main functions of glia at the synapse is to maintain ion homeostasis, for 
example regulating extracellular K+ concentrations and pH. Adopted from Eroglu et al[49].  
 
Glia are known to play an important role in controlling synapses formation and 
elimination. Neurons cultured in the presence of astrocytes have been shown to 
have ten times the excitatory synaptic activities and form five- to seven times more 
synaptic connection than if the neurons are cultured alone [49, 56, 57]. Several 
studies had also identified three distinct subtypes of signaling factors secreted by 
glia that regulate the development of glutamate-mediated synapses [49, 58] (Fig. 
11).  These glia-secreted factors either silent or strengthen synaptic connection by 
altering density of post-synaptic receptors or the probability of neurotransmitter 
release pre-synaptically. Glia have also been implicated in regulating axon pruning 
in the developing nervous system. A recent study suggests that immature astrocytes 
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secret an unidentified signaling molecule that upregulates expression of neuronal 
C1q, preferentially in weak synapses that are destined to be removed. C1q is the 
protein that initiates the classic complement pathway that results in phagocytosis. 
The mechanism with which the upregulation of C1q protein occurs preferentially in 
weak synapse is unclear. Once tagged with C1q, microglia cells, which are resident 
immune cells of the brain that contains C1q receptors on their surface, are likely 
responsible for removal of unwanted synapses [49].  
 
Fig. 11. Three classes of factors secreted by astrocytes to regulate synapse formation. A) Type I, like 
thrombospondins, results in formation of synapses that are structurally normal, but post-synaptically 
silent. B) Type II, like cholesterol, increase pre-synaptic activities and increases neurotransmitter 
releases. C) Type III, which are yet to be identified, increases post-synaptic receptors and convert 
silent synapses to functional ones. Adopted from Eroglu et al [49]. 
 
Glia are also is known to play a role during injury to the nervous system, a function 
that may be relevant in injuries such as viral infection. When insults occur to the 
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nervous system, astrocytes revert to an immature state and express molecules that 
alter synaptic formations [49]. In one study, production of proteins TSP1 and TSP2 
were shown to be increased in astrocytes after traumatic brain injury and ischemic 
stroke[49, 59]. In mice, TSP1 and TSP2 were shown in to be required for functional 
recovery after stroke, since TSP1/2-deficient mice showed impaired motor recovery, 
synaptic density and axon pruning [60].  
 
Given the gamut of important functions glia are known to play in both the developing 
and developed nervous system, it is not a surprising observation that infection of 
underlying astrocytes can result in bystander attenuation of synaptic activity and that 
it is reasonable to infer that the changes in astrocytes calcium physiology observed 
in the current experiments could play a role in the pathogenesis of congenital CMV 
infection. But given that the experiments were performed in-vitro, the true relevance 
of these findings in-vivo can only be speculated at this point. Further experiments 
that could be performed would include trying to replicate these findings in-vivo, by 
infecting embryonic mice in-utero with MCMV. The technical difficulty of performing 
calcium imaging of live brain slices will have to be overcome. Primarily, confocal 
microscopy would have to be used to perform imaging on slices. However, excitation 
of 340 and 380nm is generally not achieved using the laser available in common 
confocal microscopy. Hence, the Fura-2 calcium indicator cannot be used. Technical 
modifications to standard confocal microscopic set-up are also needed to alternate 
excitation or emission spectrum in order to accommodate ratiometric dyes. 
Obtaining clear images with large number of cells in a field of view is also 
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dramatically more difficult in live brain slices, making the collection of large amount 
of data for quantitative comparison of calcium level much more time-consuming and 
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